Approved for Prevention of dengue disease caused by dengue virus serotypes 1, 2, 3, and 4 in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection living in endemic areas. Contains four recombinant live, attenuated dengue viruses (serotypes 1–4) based on a yellow fever vaccine backbone (chimeric). Each virus expresses dengue surface proteins that stimulate……
Loading full data from Know Your Drugs Institute…